These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2682898)

  • 21. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
    Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
    Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
    Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
    Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo.
    Dobrilla G; Chilovi F; Tafner G; Vantini I; Bernardi A; Gentilini R; Fedrizzi F; Manfrini R; Steiner H; Mon M
    Ital J Gastroenterol; 1992; 24(6):338-41. PubMed ID: 1515660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
    Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
    Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisapride and cimetidine in the treatment of erosive esophagitis.
    Maleev A; Mendizova A; Popov P; Vlahov V; Dimitrov B; Mihova A; Crowe J; Silveira J; Thomson A; Routhier G
    Hepatogastroenterology; 1990 Aug; 37(4):403-7. PubMed ID: 2210608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Gut; 1988 Oct; 29(10):1386-91. PubMed ID: 3058555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.
    Behar J; Brand DL; Brown FC; Castell DO; Cohen S; Crossley RJ; Pope CE; Winans CS
    Gastroenterology; 1978 Feb; 74(2 Pt 2):441-8. PubMed ID: 340333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
    Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.
    Borkent MV; Beker JA
    Gut; 1988 Mar; 29(3):385-9. PubMed ID: 3281872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis.
    Williams RM; Orlando RC; Bozymski EM; Readling RD; Castell DO; Roufail WM; Rick GG; Rubin SE; Sinar DR
    Am J Med; 1987 Sep; 83(3B):61-6. PubMed ID: 3310630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
    Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of tri-potassium di-citrato bismuthate (De-Nol) on the healing of chronic duodenal ulcers.
    Coughlin GP; Kupa A; Alp MH
    Med J Aust; 1977 Feb; 1(9):294-8. PubMed ID: 323663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.